How to steer clear of R&D tax incentive landmines when you’re a startup
(Note: the following are general observations only and do not constitute tax advice)
Whilst the exact circumstances of Plutora’s situation is not known to members of the general public, the AFR quotes the founder as attributing the recent disruption to Plutora’s operations as having been triggered by the Australian Taxation Office unexpectedly denying the refundability of the company’s past R&D tax incentive claims.
At first glance, the apparent trigger for the ATO challenging Plutora’s prior year R&D tax incentives is not actually to do with the merits of its R&D activities. In fact, it seems that it is to do with a little understood tax concept called “aggregated turnover” (and whether Plutora’s such figure was less than $20m).
Essentially, the tax rules say that only companies with revenues of less than $20m are entitled to the refundable version of the R&D tax incentive. For other companies, their R&D incentive is non-refundable – i.e. its only use to the company is reducing its tax liabilities, which is cold comfort for loss-making tech startups who don’t have a tax liability in the first place.

Whilst it is usually fairly easy for a startup to determine whether its revenues are less than $20m, this issue gets much murkier for companies with major shareholders who either have significant revenues themselves or own significant stakes in other companies with significant revenues.
Without getting overly technical – aggregation of revenues occurs where there is a common 40% direct or indirect ownership interest. Making this issue even more tricky is the fact that ownership interest in this context could mean dividend rights, capital rights or voting rights. So it is theoretically possible for a startup to have multiple related parties whose revenues are aggregated together with the startup.
A rule of thumb for startup founders and CFOs is that whenever a shareholder’s interest reaches 40% – and this includes the founder – tax advice should be sought on how the shareholder’s revenues and other investments affect the startup’s R&D tax incentive.
“Startups usually make losses, so why is tax even relevant to the R&D claim?” I hear you say.
The reason why tax has a profound impact here lies in the name R&D tax incentive. The relevant rules are mostly found in the Tax Act, which means a company’s tax affairs affects its R&D rebate, and its R&D rebate affects its tax.
Put simply – a startup should never consider the R&D tax incentive in isolation whilst ignoring tax issues.
“Aggregated turnover” is joined by a lengthy list of other common landmines when a startup makes an R&D tax incentive claim. I won’t name them all, but here are a handful of common ones (in no particular order):
In addition to the ATO, startups must also satisfy AusIndustry, the government body that assesses the R&D claim from a technical/scientific perspective.
AusIndustry has the power to direct the ATO to deny R&D claims where it finds any of the following common deficiencies:
A common misconception is that once a startup receives the R&D incentive into its bank account, it must all be OK.
It then comes as a rude shock to learn that the ATO generally has 4 years (sometimes more) to challenge an R&D claim.
There is no secret to avoiding all this trouble – take the time and prepare the best R&D claim that you can, don’t be afraid to ask uncomfortable questions and make doubly sure that your R&D advisor understands their tax!
* Jack Qi is an accountant and advisor to the tech sector at William Buck.
Comments